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To study cell interactions in tumor development, new epi-
thelial and mesenchymal cell lines were established from
human hepatocellular carcinoma by spontaneous out-
growth in culture. We obtained several hepatocarcinoma
(HCC), B-lymphoblastoid (BLC) and myofibroblastoid
(MF) lines. In-depth characterization included cell kinet-
ics, genotype, tumorigenicity, expression of cell-type spe-
cific markers and proteome patterns. Many functions of
cells of origin were found to be preserved. Thus, HCC cells
secrete albumin and α1-antitrypsin, BLC cells phagocytose
and release TNF-β, other cytokines and reactive oxygen
species upon stimulation, while MF cells express fibulin-
2, vimentin and hepatocyte growth factor (HGF). We
studied the impact of the mesenchymal lines on hepato-
carcinogenesis by in vitro assays. BLC and MF superna-
tants strongly increased DNA replication of premalignant
hepatocytes. The stimulation by MF lines was mainly
attributed to HGF secretion. In HCC cells, MF supernatant
had only minor effects on cell growth but enhanced
migration. MF lines also stimulated neoangiogenesis via
vEGF release. BLC supernatant induced dramatically
death of HCC cells, which could be largely abrogated by
neutralizing the supernatant with TNF-β-antiserum. In
conclusion, the new cell lines reveal stage-specific stimu-
latory and inhibitory interactions between mesenchymal
and epithelial tumor cells. They offer new tools to unravel
the role of the microenvironment during hepatocarcino-
genesis.
from 13th Scientific Symposium of the Austrian Pharmacological Society (APHAR). Joint Meeting with the Austrian Society of Toxicology (ASTOX) and the 
Hungarian Society for Experimental and Clinical Pharmacology (MFT)
Vienna, Austria. 22–24 November 2007
Published: 14 November 2007
BMC Pharmacology 2007, 7(Suppl 2):A59 doi:10.1186/1471-2210-7-S2-A59
<supplement> <title> <p>13th Scientific Symposium of the Austrian Pharmacological Society (APHAR). Joint Meeting with the Austrian Society of Toxicology (ASTOX) and the Hungarian Society for Experimental and Clinical Pharmacology (MFT)</p> </title> <editor>Ernst Singer and Thomas Griesbacher</editor> <note>Meeting abstracts – A single PDF containing all abstracts in this Supplement is available <a href="[http://www.biomedcentral.com/content/files/pdf/1471-2210-7-S2-full.pdf]">here</a></note> <url>http://www.biomedcentral.com/content/pdf/1471-2210-7-S2-info.pdf</url> </supplement>
This abstract is available from: http://www.biomedcentral.com/1471-2210/7/S2/A59
© 2007 Sagmeister et al; licensee BioMed Central Ltd. 
